Menu
Recruiting NCT07301905

Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

No phase Interventional HPV Vaccination

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: General HPV Vaccine Health Messaging, Culturally Targeted HPV Vaccine Health Messaging.
Who it may be relevant to
Registry conditions: HPV Vaccination. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Culturally Targeted Messaging and Parental Receptivity to the Human Papillomavirus Vaccine

Overview

The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is: • Does culturally targeted messaging increase African American parents' intentions to vaccinate their daughter against HPV? Research will compare culturally targeted messaging to general, educational messaging and no messaging. Participants will: * View culturally targeted messages, education-only messages, or no messages about the HPV vaccine * Report their intentions to vaccinate their daughter against HPV * Report whether they have initiated HPV vaccination for their daughter six months later

Detailed description

Cervical cancer incidence and mortality are higher for African American women than for White women. The human papillomavirus (HPV) vaccine is the most effective strategy for reducing risk for cervical cancer. However, African American girls are less likely to have completed the HPV vaccine series than White girls. The present research will evaluate a culturally targeted approach to health messaging about the HPV vaccine for parents with vaccine-eligible daughters. The central hypothesis is that African American parents will have greater receptivity to the HPV vaccine after receiving culturally targeted messaging compared to parents who receive no messaging or education-only messaging about HPV vaccination. The primary aims are: 1) evaluate effects of HPV vaccine education on White and African American parents' receptivity to the HPV vaccine, and whether culturally targeted messaging enhances HPV vaccine receptivity among African American parents, 2) compare effects of education-only versus culturally targeted messaging on activation of racism-related thinking when considering child HPV vaccination, and 3) examine the effects of racism-related medical mistrust on the effectiveness of culturally targeted messaging. General and culturally targeted messaging about the HPV vaccine were developed in collaboration with community members and a local health educator. Participants will report their intentions to vaccinate their daughter against HPV immediately after viewing health messaging, as well as initiation of the HPV vaccine series for their daughter 6-months post-messaging.

Interventions

  • Behavioral General HPV Vaccine Health Messaging
    General, education-only messaging about the HPV vaccine does not include culturally targeted messaging.
  • Behavioral Culturally Targeted HPV Vaccine Health Messaging
    Educational messaging about the HPV vaccine includes culturally targeted messaging about the HPV vaccine.

Primary outcome measures

  • HPV Vaccine Attitudes [Time frame: Immediately following and 6-months post-health messaging]
  • HPV Vaccine Normative Beliefs [Time frame: Immediately following and 6-months post-health messaging]
  • HPV Vaccine Perceived Behavioral Control [Time frame: Immediately following and 6-months post-health messaging]
  • HPV Vaccine Intentions [Time frame: Immediately following and 6-months post-health messaging]
  • Vaccination Initiation [Time frame: 6-months post-health messaging]
  • Vaccination Discussion [Time frame: 6-months post-health messaging]
Secondary outcome measures (1)
  • Anticipatory Racism [Time frame: Immediately following health messaging]

Eligibility criteria

Inclusion criteria

  • Identify as Black/African American or White/Caucasian
  • Have at least one daughter who is between 8-17 years of age, who is not currently pregnant, and who has not received any doses of the HPV vaccine

Exclusion criteria

  • N/A

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

United States · 1 center
  • Flint Journal Building — Flint

Identifiers

NCT: NCT07301905 · 00630245

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗